Cargando…
Data-driven analysis and druggability assessment methods to accelerate the identification of novel cancer targets
Over the past few decades, drug discovery has greatly improved the outcomes for patients, but several challenges continue to hinder the rapid development of novel drugs. Addressing unmet clinical needs requires the pursuit of drug targets that have a higher likelihood to lead to the development of s...
Autores principales: | Beis, G., Serafeim, A.P., Papasotiriou, I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Research Network of Computational and Structural Biotechnology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9732000/ https://www.ncbi.nlm.nih.gov/pubmed/36514341 http://dx.doi.org/10.1016/j.csbj.2022.11.042 |
Ejemplares similares
-
Monobodies as tool biologics for accelerating target validation and druggable site discovery
por: Akkapeddi, Padma, et al.
Publicado: (2021) -
Novel Biomarkers and Druggable Targets in Advanced Melanoma
por: Ferrucci, Pier Francesco, et al.
Publicado: (2021) -
Identification of New Druggable Antiviral Targets by Chemical Genetics
por: Kao, Richard Y., et al.
Publicado: (2011) -
Identification of novel γ-globin inducers among all potential erythroid druggable targets
por: Yu, Lei, et al.
Publicado: (2022) -
Accelerating the Production of Druggable Targets: Eukaryotic Cell-Free Systems Come into Focus
por: Thoring, Lena, et al.
Publicado: (2019)